Overexpression of PTGS2 enhanced the chemoresistance, whereas either knocking down of PTGS2 expression or inhibition of its activity restored the sensitivity of NSCLC cells to multiple agents. Here, PTGS2 is linked to non-small cell lung carcinoma.